Neil Patil

How CMS Policies to Reverse Protections for Medicare Beneficiaries Reflect a Broader Deregulatory Push 
Apples to Oranges: Including the MA Risk Score Trend in CMS’s Estimates of MA Payments
Drug Pricing in the Era of Trump 2.0